发明名称 |
Diagnosis and treatment of cancer: I |
摘要 |
<p>A method of diagnosing cancer comprising the steps of (I) obtaining a sample containing nucleic acid and/or protein from the patient; and (ii) determining s whether the sample contains a level of SCN5A (and optionally also SCN9A) voltage-gated Na* channel nucleic acid or protein associated with cancer. A method of diagnosing breast cancer comprising the steps of (i) obtaining a sample containing nucleic acid and/or protein from the'patient; and (ii) determining whether the sample contains a level of voltage-gated Na* channel 10 nucleic acid or protein, preferably SCN5A or SCN9A, associated with cancer. A method of treating cancer comprising the step of administering to the patient an agent which selectively prevents the function of SCN5A (and optionally also SCN9A) voltage-gated Nat channel. A method of treating breast cancer comprising the step of administering to the patient an agent which selectively is prevents the function of a voltage-gated Na* channel, preferably SCN5A or SCN9A. Genetic constructs and molecules useful in such methods. The methods and compositions are particularly suited to breast cancer. N:/McibourneCases/Patent/loo -51999P5100B.AUlSpeciPs5100.AU.I Specification 2007-12-19.doe 1912/07</p> |
申请公布号 |
AU2007254583(C1) |
申请公布日期 |
2011.07.07 |
申请号 |
AU20070254583 |
申请日期 |
2007.12.20 |
申请人 |
IMPERIAL INNOVATIONS LIMITED |
发明人 |
FRASER, SCOTT PATON;COOMBES, RAOUL CHARLES;DISS, JAMES KENNETH JOSEPH;DJAMGOZ, MUSTAFA BILGIN ALI |
分类号 |
G01N33/50;A61K38/00;A61K47/48;A61K48/00;A61P35/00;C07K14/705;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12Q1/68;G01N33/15;G01N33/53;G01N33/566;G01N33/574 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|